SupplementaryTables.docx (18.2 kB)

Supplementary Material Table 1 - Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: A systematic literature review

dataset

posted on 2022-02-24, 09:33 authored by T. Alexander Russell-Smith, Laura Gurskyte, Bogdan Muresan, Carla M. Mamolo, Ana Gezin, Joseph C. Cappelleri, Bart Heeg

Supplementary Material Table 1. Search syntax

Supplementary Material Table 2. Eligibility criteria

Funding

Pfizer

History

Usage metrics

Read the peer-reviewed publication

Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: A systematic literature review

Future Oncology

Keywords

AML leukemia relapsed not eligible unfit review Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0